Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: Results from the strategic transcatheter evaluation of new therapies (STENT) group

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 7, 2008, Pages 893-900

  Brodie, Bruce R ^a,j   Stuckey, Thomas ^a   Downey, William ^a   Humphrey, Angela ^b   Nussbaum, Marcy ^b   Laurent, Sherry ^b   Bradshaw, Barbara ^a   Metzger, Chris ^c   Hermiller, James ^d   Krainin, Fred ^e   Kuk, Stanley ^f   Cheek, Barry ^g   Duffy, Peter ^h   Simonton, Charles A ⁱ  

^a LeBauer Cardiovascular Research Foundation   (United States)

^b R Stuart Dickson Institute for Health Studies   (United States)

^c Wellmont Holston Valley Medical Center   (United States)

^d Indiana Heart Institute   (United States)

^e McLeod Health   (United States)

^f Sisters of Charity Providence Hospitals   (United States)

^g High Point Regional Health System   (United States)

^h Moore Regional Hospital   (United States)

ⁱ CAROLINAS MEDICAL CENTER   (United States)

^j NONE   (United States)

more..

Author keywords

Acute coronary syndrome; Drug eluting stents; Percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

ABCIXIMAB; ENOXAPARIN; EPTIFIBATIDE; HIRULOG; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; ARTICLE; BARE METAL STENT; BLOOD VESSEL DIAMETER; BYPASS SURGERY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; STENT; STENT THROMBOSIS; THROMBOSIS; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; RISK ASSESSMENT; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 60749135658     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21767     Document Type: Article

References (22)

1. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
2. Spaulding C, Daemen J, Boersma E, Cutlip DE Serruys P. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997.
3. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent is abciximab and bare-metal stent for acute myocardial infarction. A randomized trial (STRATEGY). JAMA 2005;293:2109-2117.
4. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-1113.
5. Spaulding C, Henry P, Teiger E, et al for the TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Eng J Med 2006;355:1093-1104.
6. Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 2007;49:1924-1930.
7. Tierala I, Syvanne M, Kupari M. Comparison of paclitaxel-eluting with bare metal stents in acute myocardial infarction: The HAAMU-STENT Study. Paper presented at Transcatheter Therapeutics, Washington, DC, 2006.
8. Van der Hoeven BL, Leim SS, Jukema JW, et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcomes results from the MISSION! Intervention Study. J Am Coll Cardiol 2008;51:618-626.
9. Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 2007;153:749-754.
10. Simonton CA, Brodie BR, Cheek B, et al. Comparative clinical outcomes of paclitaxel and sirolimus-eluting stents. Results from a large prospective multicenter registry - STENT Group. J Am Coll Cardiol 2007;50:1214-1222.
11. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.
12. Hannan EL, Racz M, Walford G, et al. Drug-eluting versus bare metal stents in the treatment of patients with ST-elevation myocardial infarction. J Am Coll Cardiol Intv 2008;1:129-135.
13. Patel MR, Pfisterer ME, Betriu A, et al. Short-term outcomes are at least as good with drug-eluting stents versus bare metal stents: Insights from APEX-AMI. Paper presented at the European Society of Cardiology, Vienna, Austria, 2007.
14. Steg PG. Increased all-mortality at two year follow-up after PCI with drug-eluting stents versus bare metal stents in acute coronary syndromes: the GRACE registry. Paper presented at the European Society of Cardiology, Vienna, Austria, 2007.
15. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stent in humans delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
16. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: A serial intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:1002-1005.
17. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434.
18. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. An observational study of drug-eluting stents versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591.
19. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-168.
20. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-1956.
21. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting with or without abciximab in acute myocardial infarction. N Engl J Med 2002;346:957-966.
22. Stone GW, Witzenbichler B, Guagliumi G, et al. Comparison of bivalirudin to unfractionated heparin and glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction. New Engl J Med 2008;358:2218-2230.